Tempo Therapeutics is a clinical-stage tissue engineering company based in San Diego, California, developing synthetic biomaterials for surgical reconstruction and regenerative medicine. Its proprietary microporous annealed particle (MAP) platform assembles established hydrogel polymers into an injectable, porous scaffold that promotes vascularized tissue growth while evading the foreign body response. Lead products TT101, for complex surgical sites with exposed bone, tendon or fascia, and TT108, for fascial incision site reinforcement, are entering clinical trials, and the company is extending the platform into drug delivery, cell engraftment and vaccine applications.
1
Round
1
Industry
5
Tags
Sep 11, 2026
Latest raise
Funding activity · 1 round
Sep 11, 2026
$14M
Debt
Tempo Therapeutics Secures $14M Debt Round Tempo Therapeutics, a clinical stage tissue engineering company based in San Diego, California, has raised $14 milli…
Read articlePricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
